News
November 5, 2010 - A study performed by investigators from the Emergency Department of the Cleveland Clinic Foundation found that a noninvasive cardiac output monitor (NICOM) system is effective in identification of acute heart failure (AHF). The system, by Cheetah Medical, is also effective in differentiating AHF from other acute situations with similar clinical presentations.
November 05, 2010
News
November 5, 2010 – ST Cardio was awarded nearly $250,000 in a grant under the Qualifying Therapeutic Discovery Project Program. The grant is related to the company’s Z6 Cardiac Stimulator. The grant, which totaled $244,479, is given to projects that can result in new therapies that treat unmet needs or reduce the long-term growth of healthcare costs.
November 05, 2010News
November 5, 2010 – Cardiovascular Systems Inc. (CSI) will pay $1 million to settle an employment lawsuit with ev3, which is now part of Covidien. The litigation stems from a lawsuit ev3 originally filed in 2007 related to ev3 employees who joined Cardiovascular Systems Inc.
November 05, 2010Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
November 5, 2010 – The National Heart, Lung, and Blood Institute has awarded the University of Illinois at Chicago (UIC) more than $12 million to investigate the acquired and familial causes of heart failure. The goal is to identify markers for diagnosis and targets for cures.
November 05, 2010News
November 5, 2010 – The final patient has been enrolled in a trial studying a balloon-expandable covered stent for those with occlusive disease of the iliac artery. The iCARUS trial is investigating the iCast stent, made by Atrium Medical.
November 05, 2010News
November 5, 2010 – Stereotaxis has been awarded $1.5 million in grants under the Qualifying Therapeutic Discovery Project Program. Enacted under the Patient Protection and Affordable Care Act of 2010, the program targets projects that address unmet needs, reduce long-term healthcare costs and produce new therapies.
November 05, 2010Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
November 5, 2010 – New research shows that novel drug-coated balloon technology is being adopted in niche applications throughout Europe. The research, from the Millenium Research Group, also found that the market will continue to grow as physicians increasingly use the balloons when other devices are not suitable.
November 05, 2010
Technology
November 5, 2010 - The U.S. Food and Drug Administration (FDA) granted 510(k) clearance for the latest version of a cardiovascular ultrasound system. The GE Healthcare Vivid E9 Breakthrough 2011 (BT11) is built for 4-D imaging and features elements designed to help improve image quality, quantification and workflow.
November 05, 2010News
November 4, 2010 – GE Healthcare has signed an exclusive collaboration agreement with West Physics Consulting to provide accreditation support. The agreement will support customers seeking accreditation from the American College of Radiology (ACR) for MRI, CT, nuclear medicine and PET systems.
November 04, 2010Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
Technology
November 3, 2010 – The U.S. Food and Drug Administration (FDA) has approved a new stent delivery system for clinical practice in the United States. The Talent Thoracic Stent Graft with Captivia delivery system, by Medtronic, features a tip capture mechanism for controlled deployment and precise placement of the implantable medical device.
November 03, 2010
News
November 3, 2010 – A multicenter CE-mark study has been launched for transapical TAVI system. Hendrik Treede, M.D., performed the first implantations of the system, made by JenaValve, at the Universitäres Herzzentrum Hamburg.
November 03, 2010
News
November 3, 2010 – The first patient has been enrolled into a study comparing a left atrial appendage (LAA) closure device to warfarin therapy in those with atrial fibrillation. The PREVAIL study will look at Atritech’s Watchman LAA closure device. Central Baptist Hospital in Lexington, Ky., enrolled the first patient.
November 03, 2010Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023News
November 2, 2010 – Boston Scientific will sell its neurovascular business to Stryker for $1.5 billion in cash. Of that purchase price, $1.4 billion will be paid at closing, and the remaining $100 million will be paid upon commercialization of the Target Detachable Coils. Several manufacturing facilities will also be transferred to Stryker.
November 01, 2010News
November 1, 2010 - After a heart attack victim stops breathing, a process of irreversible brain damage starts to occur within three to four minutes. But a new technique may significantly delay that damage.
November 01, 2010Technology
Several upgrades are now available on Toshiba’s Viamo ultrasound system, including ApliPure Plus, Tissue Pure Imaging, a ...
November 01, 2010© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now